Bruynzeel DP - Search Results

1

The CXCR3 activating chemokines IP-10, Mig, and IP-9 are expressed in allergic but not in irritant patch test reactions.

Flier J, Boorsma DM, Bruynzeel DP, Van Beek PJ, Stoof TJ, Scheper RJ, Willemze R, Tensen CP. Flier J, et al. Among authors: bruynzeel dp. J Invest Dermatol. 1999 Oct;113(4):574-8. doi: 10.1046/j.1523-1747.1999.00730.x. J Invest Dermatol. 1999. PMID: 10504443 Free article.

2

Nickel-responding T cells are CD4+ CLA+ CD45RO+ and express chemokine receptors CXCR3, CCR4 and CCR10.

Moed H, Boorsma DM, Stoof TJ, von Blomberg BM, Bruynzeel DP, Scheper RJ, Gibbs S, Rustemeyer T. Moed H, et al. Among authors: bruynzeel dp. Br J Dermatol. 2004 Jul;151(1):32-41. doi: 10.1111/j.1365-2133.2004.05975.x. Br J Dermatol. 2004. PMID: 15270870

3

Induction of cytokine (interleukin-1alpha and tumor necrosis factor-alpha) and chemokine (CCL20, CCL27, and CXCL8) alarm signals after allergen and irritant exposure.

Spiekstra SW, Toebak MJ, Sampat-Sardjoepersad S, van Beek PJ, Boorsma DM, Stoof TJ, von Blomberg BM, Scheper RJ, Bruynzeel DP, Rustemeyer T, Gibbs S. Spiekstra SW, et al. Among authors: bruynzeel dp. Exp Dermatol. 2005 Feb;14(2):109-16. doi: 10.1111/j.0906-6705.2005.00226.x. Exp Dermatol. 2005. PMID: 15679580

4

Contact allergy to Nephrolepsis ferns.

Stoof TJ, Bruynzeel DP. Stoof TJ, et al. Among authors: bruynzeel dp. Contact Dermatitis. 1989 Mar;20(3):234-5. doi: 10.1111/j.1600-0536.1989.tb04671.x. Contact Dermatitis. 1989. PMID: 2524358 No abstract available.

5

The effect of occlusion of the skin with transdermal therapeutic system on Langerhans' cells and the induction of skin irritation.

Nieboer C, Bruynzeel DP, Boorsma DM. Nieboer C, et al. Among authors: bruynzeel dp. Arch Dermatol. 1987 Nov;123(11):1499-502. Arch Dermatol. 1987. PMID: 2960271 Clinical Trial.

6

Identification of anti-inflammatory drugs according to their capacity to suppress type-1 and type-2 T cell profiles.

Moed H, Stoof TJ, Boorsma DM, von Blomberg BM, Gibbs S, Bruynzeel DP, Scheper RJ, Rustemeyer T. Moed H, et al. Among authors: bruynzeel dp. Clin Exp Allergy. 2004 Dec;34(12):1868-75. doi: 10.1111/j.1365-2222.2004.02124.x. Clin Exp Allergy. 2004. PMID: 15663561

7

Differential suppression of dendritic cell cytokine production by anti-inflammatory drugs.

Toebak MJ, de Rooij J, Moed H, Stoof TJ, von Blomberg BM, Bruynzeel DP, Scheper RJ, Gibbs S, Rustemeyer T. Toebak MJ, et al. Among authors: bruynzeel dp. Br J Dermatol. 2008 Feb;158(2):225-33. doi: 10.1111/j.1365-2133.2007.08297.x. Epub 2007 Nov 19. Br J Dermatol. 2008. PMID: 18028503

8

Allergic reactions, "spillover' reactions, and T-cell subsets.

Bruynzeel DP, Nieboer C, Boorsma DM, Scheper RJ, van Ketel WG. Bruynzeel DP, et al. Arch Dermatol Res. 1983;275(2):80-5. doi: 10.1007/BF00412879. Arch Dermatol Res. 1983. PMID: 6223603

9

Angry back or the excited skin syndrome. A prospective study.

Bruynzeel DP, van Ketel WG, von Blomberg-van der Flier M, Scheper RJ. Bruynzeel DP, et al. J Am Acad Dermatol. 1983 Mar;8(3):392-7. doi: 10.1016/s0190-9622(83)70044-7. J Am Acad Dermatol. 1983. PMID: 6833539

10

Analysis of effector and regulatory immune reactivity to nickel.

Rustemeyer T, von Blomberg BM, van Hoogstraten IM, Bruynzeel DP, Scheper RJ. Rustemeyer T, et al. Among authors: bruynzeel dp. Clin Exp Allergy. 2004 Sep;34(9):1458-66. doi: 10.1111/j.1365-2222.2004.02045.x. Clin Exp Allergy. 2004. PMID: 15347381

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters